Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Bom, J.G. van der
  • (-) = Hamulyak, K.

Search results

  • RSS Feed
(1 - 8 of 8)
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
Atiq, F.; Fijnvandraat, K.; Galen, K.P.M. van; Laros-Van Gorkom, B.A.P.; Meijer, K.; Meris, J. de; ... ; WIN Study Grp 2019
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
Article / Letter to editor
metadata only
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors
Velzen, A.S. van; Eckhardt, C.L.; Streefkerk, N.; Peters, M.; Hart, D.P.; Hamulyak, K.; ... ; INSIGHT Study Grp 2016
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors
Article / Letter to editor
metadata only
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Velzen, A.S. van; Eckhardt, C.L.; Streefkerk, N.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; INSIGHT Study Grp 2014
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Article / Letter to editor
metadata only
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Loomans, J.I.; Velzen, A.S. van; Eckhardt, C.L.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Rise Study Grp 2014
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Article / Letter to editor
metadata only
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)
Loomans, J.I.; Velzen, A.S. van; Eckhardt, C.L.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Insight Rise Study Grp 2014
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)
Article / Letter to editor
metadata only
Clinical presentation of inhibitor development in non-severe hemophilia A: half of patients have high titer inhibitors and present with bleeding complications
Eckhardt, C.L.; Loomans, J.I.; Velzen, A.S. van; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Insight Study Grp 2014
Clinical presentation of inhibitor development in non-severe hemophilia A: half of patients have high titer inhibitors and present with bleeding complications
Article / Letter to editor
metadata only
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Eckhardt, C.L.; Velzen, A.S. van; Peters, M.; Astermark, J.; Brons, P.P.; Castaman, G.; ... ; INSIGHT Study Grp 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Article / Letter to editor
metadata only
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease
Wee, E.M. de; Sanders, Y.V.; Mauser-Bunschoten, E.P.; Bom, J.G. van der; Degenaar-Dujardin, M.E.L.; Eikenboom, J.; ... ; WiN Study Grp 2012
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease
Article / Letter to editor
metadata only